Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 390

A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors

A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors
Conditions:   Small Cell Lung Cancer;   Non-small Cell Lung Cancer, Squamous;   Non-small Cell Lung Cancer, Non-squamous;   Head and Neck Squamous Cell Carcinoma;   Esophageal Squamous Cell Carcinoma;   Gastric Adenocarcinoma;   Gastroesophageal Junction Adenocarcinoma
Intervention:   Drug: ladiratuzumab vedotin
Sponsor:   Seattle Genetics, Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 28, 2019 / by / in
Comments